These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9481469)
1. Respiratory syncytial virus immune globulin intravenous (human) receives marketing approval in Canada. Langley JM Can Fam Physician; 1998 Jan; 44():113. PubMed ID: 9481469 [No Abstract] [Full Text] [Related]
2. Prevention of respiratory syncytial virus infection in high risk infants: consensus opinion on the role of immunoprophylaxis with respiratory syncytial virus hyperimmune globulin. Meissner HC; Welliver RC; Chartrand SA; Fulton DR; Rodriguez WJ; Groothuis JR Pediatr Infect Dis J; 1996 Dec; 15(12):1059-68. PubMed ID: 8970212 [No Abstract] [Full Text] [Related]
3. Novel mutations in the respiratory syncytial virus G gene identified in viral isolates from a girl with severe combined immune deficiency treated with intravenous immune globulin. Lazar I; Canaan A; Weibel C; Kahn JS J Clin Virol; 2006 Nov; 37(3):168-73. PubMed ID: 16949862 [TBL] [Abstract][Full Text] [Related]
4. Quantitative effects of palivizumab and donor-derived T cells on chronic respiratory syncytial virus infection, lung disease, and fusion glycoprotein amino acid sequences in a patient before and after bone marrow transplantation. El Saleeby CM; Suzich J; Conley ME; DeVincenzo JP Clin Infect Dis; 2004 Jul; 39(2):e17-20. PubMed ID: 15307047 [TBL] [Abstract][Full Text] [Related]
5. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627 [TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus immune globulin and conflict of interest. Groothuis JR N Engl J Med; 1998 Nov; 339(22):1644. PubMed ID: 9867534 [No Abstract] [Full Text] [Related]
10. Prophylaxis against respiratory syncytial virus in high-risk infants: administration of immune globulin and epidemiological surveillance of infection. Handal G; Logvinoff MM; Zegarra N; Allen L; Jesurun A; Levin G; Thida A Tex Med; 2000 May; 96(5):58-61. PubMed ID: 10843015 [TBL] [Abstract][Full Text] [Related]
11. New guidelines proposed for use of RSV immune globulin. Am J Health Syst Pharm; 1997 May; 54(9):1025. PubMed ID: 9143648 [No Abstract] [Full Text] [Related]
12. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience. DeVincenzo JP; Hirsch RL; Fuentes RJ; Top FH Bone Marrow Transplant; 2000 Jan; 25(2):161-5. PubMed ID: 10673674 [TBL] [Abstract][Full Text] [Related]
13. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Simoes EA; Carbonell-Estrany X Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448 [TBL] [Abstract][Full Text] [Related]
14. Immunoprophylaxis of respiratory syncytial virus infection. Simoes EA Indian Pediatr; 2000 Mar; 37(3):243-7. PubMed ID: 10750065 [No Abstract] [Full Text] [Related]
15. Prophylaxis for severe respiratory syncytial virus disease. Kupecz D Nurse Pract; 1996 Sep; 21(9):116-8. PubMed ID: 8884798 [No Abstract] [Full Text] [Related]